22:42 , May 21, 2019 |  BioCentury  |  Finance

Debt and equity investor K2HV seeks ‘profit and purpose’ in $400M launch

Newly launched venture debt and equity investor K2 HealthVentures says it will redirect some of its returns to “underserved and underinvested” areas of the life sciences and healthcare sphere as it invests the first $400...
18:33 , Dec 14, 2018 |  BC Week In Review  |  Company News

Millendo, OvaScience merge, raise $50M

Emerging from the reverse-merger of private endocrine company Millendo Therapeutics Inc. and former public fertility company OvaScience Inc., Millendo Therapeutics Inc. (NASDAQ:MLND) raised $49.5 million in a financing Friday. The combined company will begin trading...
17:50 , Dec 7, 2018 |  BC Extra  |  Company News

Millendo, OvaScience merge, raise $50M

Emerging from the reverse-merger of private endocrine company Millendo Therapeutics Inc. and former public fertility company OvaScience Inc., Millendo Therapeutics Inc. (NASDAQ:MLND) raised $49.5 million in a financing Friday. The combined company will begin trading...
01:01 , Jan 31, 2018 |  BC Extra  |  Company News

Amazon, Berkshire, JPM healthcare deal rocks incumbents

Leading managed care organizations (MCOs), drug distributors and retailers lost more than $32 billion combined in market cap Tuesday on the news that Amazon.com Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK-A; NYSE:BRK-B) and JPMorgan Chase &...
05:09 , Nov 17, 2017 |  BC Week In Review  |  Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
22:39 , Nov 15, 2017 |  BC Extra  |  Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
20:58 , Oct 13, 2017 |  BioCentury  |  Finance

Sprucely debut

Spruce Biosciences Inc. emerged from stealth mode on Oct. 12, unveiling a $20 million series A round the company says will fund an ongoing Phase II study for a rare endocrine indication and could propel...
22:30 , Jul 21, 2017 |  BC Extra  |  Company News

Cardinal seeking buyer for China distribution business

In a statement , Cardinal Health Inc. (NYSE:CAH) said it has "begun to explore strategic alternatives to support its next stage of growth" for its Cardinal Health China distribution business. The statement followed media reports...
16:16 , Jan 26, 2017 |  BC Innovations  |  Distillery Techniques

Drug platforms

TECHNOLOGY: Structural analyses Crystallographic analyses of H. pylori cah bound to sulfonamides could help guide the design of inhibitors to treat H. pylori infection. Comparative crystallographic studies of bacterial cah and human carbonic anhydrase II...
01:07 , Dec 10, 2016 |  BC Extra  |  Company News

Management tracks

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Deborah Waterhouse will succeed Dominique Limet at CEO of Viiv Heathcare, its HIV-focused joint venture with Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507). Limet is to step down...